TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

However, the test could only predict MS flare-ups out to one year. The test reflects current or recent nerve damage, "which makes it excellent for short-term risk assessment," Martinez-Serrat said.

The multiple sclerosis report looked back five years. About 3 million people worldwide have MS, the most common cause of disability – save traumatic injury – among young adults.

Relapsing-remitting MS (RRMS) RRMS is the most common type of the disease. According to the National Multiple Sclerosis Society, about 85% of people with MS have RRMS at the time of diagnosis.

However, the test could only predict MS flare-ups out to one year. The test reflects current or recent nerve damage, “which makes it excellent for short-term risk assessment," Martinez-Serrat said.

The lack of detailed characterization of T2/FLAIR lesion volume, shape, and location and the absence of centralized, blinded MRI review were cited as further limitations.

Multiple sclerosis (MS) is a demyelinating disease that affects the central nervous system (CNS) and is characterized by the presence of CNS lesions. Volumetric measures of tissues, including lesions, ...

For each of these inputs there must be a folder with the DICOMs (e.g. the folder named CT1 or T2) OR a NIfTI file (the file named e.g. CT1.nii or T2.nii.gz). If multiple possible inputs are present ...

In the brain MRI, both parieto-occipital and frontal T2/FLAIR hyperintensities can be found, as well as hyperintensities in the splenium of the corpus callosum. The combination of both patterns is ...